×

SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal
Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
　
CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016
Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients
Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
　
ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238
Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria
Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
　
INT J EPIDEMIOL 2020 10.1093/ije/dyaa089
Risk of hepatocellular carcinoma in individuals without traditional risk factors development and validation of a novel risk score
Sinn1, DH; Kang, D; Cho, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
　
DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events
Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
　
J VIRAL HEPATITIS 2020 10.1111/jvh.13279
Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients
Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
　
CANCERS 2020 10.3390/cancers12051300
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
Yu1, JI; Park, HC; Yoo, GS; Paik, SW; Choi, MS; Kim, HS; Sohn, I; Nam, H
　
GUT LIVER 2020 10.5009/gnl18100
Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C
Ahn1, SH; Choe, WH; Kim, YJ; Heo, J; Latarska-Smuga, D; Kang, J; Paik, SW
　
J VIRAL HEPATITIS 2020 10.1111/jvh.13304
Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study
Hong1, CY; Sinn, DH; Kang, D; Paik, SW; Guallar, E; Cho, J; Gwak, GY
　
PLoS One 2020 10.1371/journal.pone.0230893
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B
Marcellin1, P; Xie, Q; Paik, SW; Flisiak, R; Piratvisuth, T; Petersen, J; Asselah, T; Cornberg, M; Ouzan, D; Foster, GR; Papatheodoridis, G; Messinger, D; Regep, L; Bakalos, G; Alshuth, U; Lampertico, P; Wedemeyer, H
　
TRANSPL P 2020 10.1016/j.transproceed.2020.01.037
Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma
Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS
　
J CLIN ENDOCR METAB 2020 10.1210/clinem/dgz040
Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study
Sinn1, DH; Kang, D; Cho, SJ; Chang, Y; Ryu, S; Bin Song, Y; Paik, SW; Hong, YS; Zhao, D; Guallar, E; Cho, J; Gwak, GY
　
KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040
Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea
Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

CLIN MOL HEPATOL 2019 10.3350/cmh.2019.0006
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
Lee1, YJ; Heo, J; Kim, D; Chung, WJ; Tak, WY; Kim, YJ; Paik, SW; Sim, E; Kulasingam, S; Talwani, R; Haber, B; Hwang, P

Cancer Med 2019 10.1002/cam4.2570
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
Yu1, JI; Lee, SJ; Lee, J; Lim, HY; Paik, SW; Yoo, GS; Choi, C; Park, HC

J GASTROEN HEPATOL 2019 10.1111/jgh.14750
Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia
Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

SCI REP-UK 2019 10.1038/s41598-019-50594-2
Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK

J GASTROEN HEPATOL 2019 10.1111/jgh.14856
Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Sinn1, DH; Kang, D; Chang, Y; Ryu, S; Cho, SJ; Paik, SW; Song, YB; Pastor-Barriuso, R; Guallar, E; Cho, J; Gwak, GY

EUR J ENDOCRINOL 2019 10.1530/EJE-19-0143
Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study
Sinn1, DH; Kang, D; Choi, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY

Oncoimmunology 2019 10.1080/2162402X.2019.1615817
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)
Moehler1, M; Heo, J; Lee, HC; Tak, WY; Chao, Y; Paik, SW; Yim, HJ; Byun, KS; Baron, A; Ungerechts, G; Jonker, D; Ruo, L; Cho, M; Kaubisch, A; Wege, H; Merle, P; Ebert, O; Habersetzer, F; Blanc, JF; Rosmorduc, O; Lencioni, R; Patt, R; Leen, AM; Foerster, F; Homerin, M; Stojkowitz, N; Lusky, M; Limacher, JM; Hennequi, M; Gaspar, N; McFadden, B; De Silva, N; Shen, D; Pelusio, A; Kirn, DH; Breitbach, CJ; Burke, JM

J HEPATOL 2019 10.1016/j.jhep.2018.11.029
Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial
Park1, JW; Kim, YJ; Kim, DY; Bae, SH; Paik, SW; Lee, YJ; Kim, HY; Lee, HC; Han, SY; Cheong, JY; Kwon, OS; Yeon, JE; Kim, BH; Hwang, J

BMC CANCER 2019 10.1186/s12885-019-5508-5
Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study
Sinn1, DH; Kang, D; Kang, M; Paik, SW; Guallar, E; Cho, J; Gwak, GY

PLoS One 2019 10.1371/journal.pone.0213547
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW

PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

ANTICANCER RES 2018 10.21873/anticanres.12808
Treatment of Naive HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection Versus TACE Followed by Radiotherapy
Yu1, JI; Choi, GS; Lim, DH; Lee, E; Joh, JW; Kwon, CHD; Kim, JM; Kim, S; Woo, SY; Paik, SW; Park, HC

LIVER INT 2018 10.1111/liv.13732
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW

J HEPATOL 2018 10.1016/j.jhep.2018.01.024
Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma
Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ

SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

ANN SURG TREAT RES 2018 10.4174/astr.2018.94.4.183
Prognosis of preoperative positron emission tomography uptake in hepatectomy patients
Kim1, JM; Kwon, CHD; Joh, JW; Sinn, DH; Choi, GS; Paik, SW

SCI REP-UK 2018 10.1038/s41598-018-23014-0
Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study
Jang1, HR; Kang, D; Sinn, DH; Gu, S; Cho, SJ; Lee, JE; Huh, W; Paik, SW; Ryu, S; Chang, Y; Shafi, T; Lazo, M; Guallar, E; Cho, J; Gwak, GY

NEW ENGL J MED 2018 10.1056/NEJMoa1702417
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
Zeuzem1, S; Foster, GR; Wang, S; Asatryan, A; Gane, E; Feld, JJ; Asselah, T; Bourliere, M; Ruane, PJ; Wedemeyer, H; Pol, S; Flisiak, R; Poordad, F; Chuang, WL; Stedman, CA; Flamm, S; Kwo, P; Dore, GJ; Sepulveda-Arzola, G; Roberts, SK; Soto-Malave, R; Kaita, K; Puoti, M; Vierling, J; Tam, E; Vargas, HE; Bruck, R; Fuster, F; Paik, SW; Felizarta, F; Kort, J; Fu, B; Liu, R; Ng, TI; Pilot-Matias, T; Lin, CW; Trinh, R; Mensa, FJ